Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Uloric Heart Problems Result In Health Warning in Canada November 11, 2019 Russell Maas Add Your Comments Health officials in Canada have announced a new warning about the potential heart problems from Uloric, indicating that a recent study found that the gout medication may increase the risk of heart attack, stroke and death. The Uloric warning was announced by the Government of Canada last week, advising healthcare professionals to only use Uloric as an alternative gout treatment, after a recently released study associated the use of the drug with increased risks of fatal heart problems. Uloric (febuxostat) is a Takeda Pharmaceuticals medication that is designed to lower the blood uric levels among adults diagnosed with gout, which quickly became a blockbuster drug after it was introduced in 2009. However, post-market clinical trials released in recent months have suggested that side effects of Uloric may be more serious than the drug maker first indicated. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the Canadian warning, the Uloric label has been updated to include a revised indications about use and safety, requiring a Serious Warning and Precautions Box to indicate its increased risk of cardiovascular death. In addition to the boxed warning update, Canadian officials are warning prescribing doctors to only issue Uloric for the treatment of gout if a patient has an inadequate response or intolerance to allopurinol, which is an alternative medication used to reduce blood uric levels among adults. The warning indicates Uloric should not be recommended for patients with ischemic heart disease or congestive heart failure conditions, and if necessary to prescribe Uloric, the patients should be closely monitored for signs and symptoms of myocardial infarction, stroke and cardiac failure. The warning was issued in response to findings the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) trial, which found a higher rate of fatalities among patients taking Uloric for gout treatment compared to those prescribed allopurinol. The CARES trial specifically evaluated the cardiovascular disease (CV) risk of Uloric in patients with gout who had a history of major CV disease, cerebrovascular disease, or diabetes mellitus with micro- macrovascular disease. The study concluded there was a higher rate of CV death in patients treated with Uloric, 134 deaths, compared to patients treated with allopurinol, 100 deaths. The Canadian Uloric warning follows a similar action taken by the U.S. Food and Drug Administration (FDA) earlier this year. On February 21, officials from the FDA announced the Uloric “boxed” warning, indicating that the prominently placed label information will be required to inform consumers and the medical community about the risk of cardiovascular injury and overall death from combining medications or existing health problems while taking Uloric. Given the serious risk, the warning was placed in a black box at the top of the label, which is the strongest warning the FDA can require a drug maker to place on their product. The warning is designed to make sure patients and doctors are aware of increased risks associated with use of Uloric instead of allopurinol, which is an alternative uric acid reduction medication. FDA officials also updated the Medication Guide to indicate that Uloric should only be prescribed as a secondary medication, when patients taking allopurinol experience severe side effects. Concerns regarding the gout drug were raised after the FDA issued a safety warning in 2017. The warning indicated the agency was investigating deaths linked to Uloric, including cardiovascular deaths and deaths related to interactions with other drugs, including bone marrow failure, severe bleeding and kidney failure. While there were some signs of potential heart risks with Uloric when the medication was first released, it appears that the agency did not understand the true scope of the problems until Takeda released the results of a post-marketing clinical trial. However, growing evidence suggests that Takeda knew or should have known about the risks, yet continued to market the drug without adequate warnings. Tags: Gout, Heart Disease, Takeda Pharmaceuticals, Uloric Image Credit: | More Lawsuit Stories Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries July 7, 2025 Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 July 7, 2025 Processed Food Marketing Can Have Dramatic Effect on Youth Consumption: Study July 7, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025) Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries July 7, 2025
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 July 7, 2025
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)